BofA lowered the firm’s price target on Accolade to $7 from $14 and keeps a Buy rating on the shares. The firm is reducing the multiple to reflect a lower growth profile and peer group multiple compression. BofA notes Accolade’s Q1 results were generally in line with expectations, with revenue and EBITDA in-line with Street/BofA estimates when adjusting for a $6M PG revenue pull forward in the quarter. However, management is focusing on profitability and is moderating marketing spend.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD: